Tufts Health Plan, Henry Ford Health System and Highmark Health all chipped in as care provider Kaiser Permanente's corporate VC unit closed its latest fund.

Gene therapy developer Limelight Bio grew from research at University of Pennsylvania and has landed $75m in its first publicly-disclosed round.

Mac Ventures will receive support from Yeshiva University business school students, making early-stage investments in a number of tech-oriented sectors.

The cancer drug developer emerged from stealth with $194m in funding, $85m of which was just closed in a round featuring returning investor Roche Venture Fund.

Pfizer Ventures led the immuno-oncology drug developer's latest round, which was spun out of Institut Paoli-Calmettes with the help of Satt Sud-Est and Inserm Transfert.

Pfizer Ventures led the immuno-oncology drug developer's latest round, which included existing backer Boehringer Ingelheim Venture Fund.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Impulse Dynamics, the developer of an implant for heart failure treatment, has collected $80.3m from investors including Zoll Medical, Abiomed and Minth Group.

Vanderbilt University joined fellow LPs including Consumer Technology Association in an oversubscribed close for the diversity-focused Harlem Partners Venture Fund I.

Echo Health Ventures added $7.5m to a round that already included GV and Centene, helping the mental health care provider expand it to $67.5m.